@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix owl: . @prefix dc: . @prefix xsd: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-BHDSGMFD-3 mesh:pharmacologicalAction jvr:-VVKKLXFF-N, jvr:-X5BRM0BB-H ; skos:altLabel "5I5Y2789ZF"@fr, "5I5Y2789ZF"@en, "21809-21-2 (oxalate (1:1))"@fr, "21809-21-2 (oxalate (1:1))"@en, "OQW30I1332"@fr, "OQW30I1332"@en, "46817-91-8 (Viloxazine)"@fr, "46817-91-8 (Viloxazine)"@en, "Morpholine, 2-((2-ethoxyphenoxy)methyl)-"@en, "Morpholine, 2-((2-ethoxyphenoxy)methyl)-"@fr, "52730-45-7 ((R)-isomer)"@fr, "52730-45-7 ((R)-isomer)"@en, "52697-25-3 ((+-)-isomer)"@fr, "52697-25-3 ((+-)-isomer)"@en, "35604-67-2 (HCl)"@fr, "35604-67-2 (HCl)"@en, "56287-61-7 (HCl, (S)-isomer)"@fr, "56287-61-7 (HCl, (S)-isomer)"@en, "56287-63-9 (HCl, (R)-isomer)"@fr, "56287-63-9 (HCl, (R)-isomer)"@en, "52730-46-8 ((S)-isomer)"@fr, "52730-46-8 ((S)-isomer)"@en ; mesh:allowableQualifier jvr:-G4R176S9-J, jvr:-L6C0XPHT-4, jvr:-NKM836P1-M, jvr:-NFTHND7Q-8, jvr:-H7K65Q8S-Z, jvr:-TJHVZCRZ-0, jvr:-W6SQV79N-S, jvr:-WK5F724J-1, jvr:-R0ZCQ8X6-J, jvr:-S0CS1X5R-5, jvr:-HQRFT0C6-B, jvr:-THHNVC7V-3, jvr:-SBNWSM1T-R, jvr:-FWD2BGQ0-9, jvr:-BT300B3G-Q, jvr:-CB30NGKB-3, jvr:-Q3979798-W, jvr:-G30ZJ446-J, jvr:-T9HQD7ST-J, jvr:-R3QWLHRG-V, jvr:-NHL3D2X0-S, jvr:-XV06LPML-W, jvr:-D0F21513-5, jvr:-M63HSDM7-1, jvr:-NB0XHT3S-N ; skos:hiddenLabel "Chlorhydrate de viloxazine"@fr, "Viloxazine, (R)-Isomer"@en, "Vivalan"@en, "ICI-58,834"@fr, "ICI-58,834"@en, "ICI58,834"@fr, "Viloxazine Oxalate (1:1)"@en, "Viloxazine Hydrochloride"@en, "ICI58834"@fr, "Viloxazine Hydrochloride, (S)-Isomer"@en, "Emovit"@en, "Viloxazine, (S)-Isomer"@en, "Oxalate de viloxazine"@fr, "Viloxazine, (+-)-Isomer"@en, "Viloxazine Hydrochloride, (R)-Isomer"@en ; skos:prefLabel "Viloxazine"@en, "Viloxazine"@fr ; a mesh:Descriptor, skos:Concept ; owl:sameAs ; dc:modified "2017-05-24"^^xsd:date ; dc:established "1991-01-01"^^xsd:date ; skos:inScheme jvr: ; skos:definition "A morpholine derivative used as an antidepressant. It is similar in action to IMIPRAMINE."@en ; skos:broader jvr:-V65MV4BC-P ; dc:created "1976-04-13"^^xsd:date . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-VVKKLXFF-N skos:prefLabel "Adrenergic Uptake Inhibitors"@en, "Inhibiteurs de la capture adrénergique"@fr ; a mesh:Descriptor, skos:Concept . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-X5BRM0BB-H skos:prefLabel "Antidépresseurs de seconde génération"@fr, "Antidepressive Agents, Second-Generation"@en ; a mesh:Descriptor, skos:Concept . jvr:-V65MV4BC-P skos:prefLabel "Morpholines"@fr, "Morpholines"@en ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-BHDSGMFD-3 . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept .